Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 30;15(1):514.
doi: 10.1007/s12672-024-01184-w.

The role of the ceRNA network mediated by lncRNA SNHG3 in the progression of cancer

Ying Peng  1   2   3 , Xi-Dai Long  4   5
Affiliations
Review

The role of the ceRNA network mediated by lncRNA SNHG3 in the progression of cancer

Ying Peng et al. Discov Oncol. .

Abstract

Background: Long non-coding RNAs (lncRNAs) are a distinct class of RNAs with longer than 200 base pairs that are not translated into proteins. Small Nucleolar RNA Host Gene 3 (SNHG3) is a lncRNA and frequently dysregulated in various human cancers.

Objective: This review provides a comprehensive analysis of current research on lncRNA SNHG3, focusing on its role within the competitive endogenous RNA (ceRNA) network and its implications in cancer.

Methods: A systematic literature review was conducted using PubMed up to October 2023. The search strategy included keywords such as "lncRNA SNHG3", "competitive endogenous RNA", "cancer", and related terms. Studies were selected based on relevance to SNHG3's involvement in cancer pathogenesis and progression.

Results: Disruptions in the ceRNA network involving lncRNA SNHG3 can impair normal cell growth and differentiation, significantly contributing to disease pathogenesis, particularly cancer. This review highlights SNHG3's substantial impact on various cancer processes and its potential as a diagnostic and therapeutic tool for aggressive cancers.

Conclusion: The findings underscore SNHG3's pivotal role in cancer prevention, diagnosis, and treatment, laying a foundation for future research in cancer management. Insights from this review emphasize the necessity for further exploration and development of SNHG3-based diagnostic and therapeutic strategies.

Keywords: Competitive endogenous RNAs; Human cancer; LncRNA SNHG3,; Long non-coding RNA; Potential therapeutic target,; Tumorigenesis biomarker,.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Expression Analysis of SNHG3 in 33 Types of Cancer Compared to Normal Tissues
Fig. 2
Fig. 2
ceRNA Mechanism of lncRNA SNHG3 in Various Cancers
See this image and copyright information in PMC

References

    1. Mertens D, Stilgenbauer S. Prognostic and predictive factors in patients with chronic lymphocytic leukemia: relevant in the era of novel treatment approaches? J Clin Oncol. 2014;32(9):869–72. 10.1200/jco.2013.53.8421. - PubMed
    1. Wagner S, Sharma SJ, Wuerdemann N, Knuth J, Reder H, Wittekindt C, et al. Human papillomavirus-related head and neck cancer. Oncol Res Treat. 2017;40(6):334–40. 10.1159/000477252. - PubMed
    1. Mranda GM, Xiang ZP, Liu JJ, Wei T, Ding Y. Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway. Front Oncol. 2022. 10.3389/fonc.2022.937957. - PMC - PubMed
    1. Magri V, Boltri M, Cai T, Colombo R, Cuzzocrea S, De Visschere P, et al. Multidisciplinary approach to prostatitis. Arch Ital Urol Androl. 2019;90(4):227–48. 10.4081/aiua.2018.4.227. - PubMed
    1. Kitagawa M, Kitagawa K, Kotake Y, Niida H, Ohhata T. Cell cycle regulation by long non-coding RNAs. Cell Mol Life Sci. 2013;70(24):4785–94. 10.1007/s00018-013-1423-0. - PMC - PubMed

LinkOut - more resources